Please try another search
Godavari Drugs Limited is an India-based company, which is engaged in the business of manufacturing application programming interfaces (API’s), drug intermediaries and fine chemicals. The Company also has active loan licenses and contract manufacturing tie-ups with multinational companies for API’s and drug intermediates. It serves the global life science industry. Its API products offering includes Ciprofloxacin HCl USP/EP/BP/IP, Ciprofloxacin (Base) USP/EP/BP/IP, Ciprofloxacin Lactate IH, Ciprofloxacin Betaine IH, Mefenamic Acid USP/EP/BP/IP, Enrofloxacin USP/EP/BP/IP and Elthambutoal HCI USP/BP/IP. Its intermediates include A D Lactone (for Spironolactone) and 6 Mercaptopurine (for Azathioprine). The Company's manufacturing facilities are located at the Maharashtra Industrial Development Corporation estate at Nanded, Maharashtra, India. The facility has multiple production blocks for API’s, drug intermediates and fine chemicals.
Name | Age | Since | Title |
---|---|---|---|
Mukund Kakani | 69 | - | CEO, MD & Director |
Ghanshyam Jaju | 74 | 2006 | Chairman |
Mohit Jaju | 51 | 2012 | CFO & Whole Time Director |
Syed Anis Hussain | 84 | 2005 | Non-Executive Independent Director |
Vimala Behram Madon | - | 2015 | Non-Executive Independent Director |
Mahendra Uday Bhalerao | - | 2022 | Non-Executive Independent Director |
Dinesh Udpa | - | 2024 | Additional Non-Executive Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review